Immune-checkpoint inhibitors plus chemotherapy versus chemotherapy as first-line treatment for patients with extensive-stage small cell lung cancer

We performed a meta-analysis to comprehensively investigate the efficacy and safety of immune-checkpoint inhibitors (ICIs) plus chemotherapy in patients with extensive-stage small cell lung cancer (ES-SCLC). The primary outcome was overall survival (OS). The secondary outcomes included progression-f...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Immunother Cancer
Main Authors: Zhou, Fei, Zhao, Wencheng, Gong, Xiaomei, Ren, Shengxiang, Su, Chunxia, Jiang, Tao, Zhou, Caicun
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2020
Teme:
Commentary
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7477983/
https://ncbi.nlm.nih.gov/pubmed/32900864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001300
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki